Ongoing Collaborations

MISSION Therapeutics maintains a broad network of industrial and academic collaborators, including with:

babrahamcancer-researchgurdon

 
cambridgeInnovate UK

 

MISSION Therapeutics has been awarded a £1.9 million grant from Innovate UK to support the discovery and preclinical development of inhibitors directed against a specific DUB.